OAC
INDV icon

OMERS Administration Corp’s Indivior Pharmaceuticals INDV Stock Holding History

OMERS Administration Corp’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$447K Sell
10,890
-8,324
-43% -$302K ﹤0.01% 803
2026
Q1 		$586K Sell
19,214
-17,583
-48% -$581K ﹤0.01% 746
2025
Q4 		$1.32M Buy
+36,797
New +$1.12M 0.01% 484

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OMERS Administration Corp's INDV Position: Q2 2026 in Review

OMERS Administration Corp reduced its Indivior Pharmaceuticals (INDV) stake by 43% in Q2 2026, selling an estimated $302K and leaving 10,890 shares worth $447K. The position accounts for ﹤0.01% of the portfolio, ranked #803.

OMERS Administration Corp first reported a position in INDV in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.32M in Q4 2025. 339 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • OMERS Administration Corp held 10,890 shares of Indivior Pharmaceuticals worth $447K as of Q2 2026.
  • OMERS Administration Corp sold 8,324 Indivior Pharmaceuticals shares in Q2 2026, an estimated $302K.
  • Indivior Pharmaceuticals made up ﹤0.01% of OMERS Administration Corp's portfolio in Q2 2026, its #803 holding.
  • OMERS Administration Corp first reported a position in Indivior Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • OMERS Administration Corp's Indivior Pharmaceuticals position peaked at $1.32M in Q4 2025.
  • 339 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.